Tongji Hospital
Wuhan, Hubei, China
Location status: Recruiting
NCT Number: NCT07399236
This multicenter, retrospective study aims to develop and validate a multimodal deep learning model for predicting the risk of metachronous liver metastasis in patients with stage I-III colorectal cancer following curative resection. The model will integrate preoperative contrast-enhanced CT imaging, digitized histopathological whole-slide images, and standard clinical-pathological data.
The primary objective is to assess the model's discriminatory performance, measured by the area under the receiver operating characteristic curve (AUC), and to compare its predictive accuracy against traditional prognostic factors such as TNM staging and serum carcinoembryonic antigen levels. This research utilizes existing archival data; no direct patient contact or intervention is involved. The ultimate goal is to provide a robust, data-driven tool for improved risk stratification, which could potentially guide personalized surveillance strategies and adjuvant therapy decisions in the future.
Interested in participating?
Request Info18 year–75 year
All sexes
Observational
Wuhan, Hubei, China
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This is a non-interventional study. The primary study procedure is the application of a multimodal deep learning model to retrospectively analyze existing clinical data (contrast-enhanced CT images, digitized pathology slides, and structured clinical variables) for the purpose of predicting the risk of metachronous liver metastasis. No therapeutic or diagnostic interventions are administered to participants as part of this research protocol.
Time frame: up to 3 years
The discriminatory performance of the multimodal deep learning model for predicting the 3-year risk of metachronous liver metastasis. The model integrates preoperative contrast-enhanced CT images, digitized whole-slide pathology images, and clinical data. The AUC will be calculated on the held-out independent test set. The assessment is based on data collected from the date of curative surgery (baseline) to the date of first imaging-confirmed liver metastasis or last follow-up.
Time frame: up to 3 years
The difference in liver metastasis-free survival between the high-risk and low-risk groups as stratified by the multimodal model. LMFS is defined as the time from surgery to the first radiological diagnosis of liver metastasis. From the date of surgery until the date of first documented liver metastasis or last follow-up.
Contact information is provided by the study sponsor or research team.
Tongji Hospital
Other
A Multicenter, Retrospective, Observational Study to Develop and Validate a Multimodal Deep Learning Model for Predicting Metachronous Liver Metastasis in Colorectal Cancer Patients After Curative Resection
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07224724
Colonic Diseases, Colorectal Cancer Liver Metastases (CRLM)
Duarte, California, United States
View Trial DetailsNCT07544784
Colorectal Cancer Liver Metastases (CRLM)
Shanghai, China
View Trial DetailsNCT05428735
Colorectal Cancer Liver Metastases (CRLM), Small Future Liver Remnant (FLR)
New Haven, Connecticut, United States
View Trial DetailsNCT07570914
Colonic Diseases, Colorectal Cancer
View Trial Details